2Ye P,Chen B,Wang S,et al. Association of polymorphisms of the apolipoprotein B gene with coronary heart disease in Hart Chinese,Atherosclerosis, 1995,117( 1 ) :43 -50.
3Maron D J, Fazio S, Linton M F. Current perspectives on statin. Circulation,2000,101:207 - 213.
4Bustos C, Hernandez - presa M A, Ortego M, et al. HMG - CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol, 1998,32:2057 - 2064.
5Willams JK, Sukova GL, Herrington DM ,et al. Pravastatin has cholesterol-llowering independent effects on the artery wall of atherosclerotic monleys. J Am Coil Carrliol,1998 ,31:684 -691.
6Maruca V, Stephan F, Klaudia A, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artety disease. Circulation ,2001,103:2885 - 2890.
7Kureishe Y,Luo Z, Shiojima I,et al. The HMG - CoA reductase inhibition simvastatin activates the protem kinase Akt andpronmotes angiogenesis in normocholesterolemic animals. Nat Med ,2000,6 : 1004 - 1010.
9Krone W, Muller WD. Lipid lowering therapy and stabilization of atherosclerotic plaques. Thromb Haemost, 1999,82(Suppl 1):60-61.
10Crisby M, Nordin FG, Shah PK, et al. Pravastatin treatment increases col-lagen content and decreases lipid conent, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque sta-bilization. C irculation, 2001,103: 926-933.
